These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 25376450)

  • 21. Bleeding and antidotes in new oral anticoagulants.
    Majeed A; Schulman S
    Best Pract Res Clin Haematol; 2013 Jun; 26(2):191-202. PubMed ID: 23953907
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New oral anticoagulants: an emergency department overview.
    Wood P
    Emerg Med Australas; 2013 Dec; 25(6):503-14. PubMed ID: 24224462
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug and dietary interactions of the new and emerging oral anticoagulants.
    Walenga JM; Adiguzel C
    Int J Clin Pract; 2010 Jun; 64(7):956-67. PubMed ID: 20584229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of efficacy and safety of dabigatran, rivaroxaban and apixaban in patients with atrial fibrillation using network meta-analysis.
    Harenberg J; Marx S; Diener HC; Lip GY; Marder VJ; Wehling M; Weiss C
    Int Angiol; 2012 Aug; 31(4):330-9. PubMed ID: 22801398
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New oral anticoagulants and risks in ENT.
    Hollis S
    Clin Otolaryngol; 2013 Aug; 38(4):355-7. PubMed ID: 23957550
    [No Abstract]   [Full Text] [Related]  

  • 26. Direct oral anticoagulants in atrial fibrillation.
    Noll G; Noll S; Hürlimann D
    Semin Hematol; 2014 Apr; 51(2):139-46. PubMed ID: 24861798
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bleeding with dabigatran, rivaroxaban, apixaban. No antidote, and little clinical experience.
    Prescrire Int; 2013 Jun; 22(139):155-9. PubMed ID: 23866358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel oral anticoagulants--key messages for the angiologist.
    Haas S; Spannagl M; Schellong SM
    Vasa; 2012 May; 41(3):177-91. PubMed ID: 22565619
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Laboratory tests and the new oral anticoagulants.
    Tripodi A
    Thromb Res; 2012 Oct; 130 Suppl 1():S95-7. PubMed ID: 23026677
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Gastrointestinal bleeding under treatment with new oral anticoagulants].
    Konturek P; Hess T
    MMW Fortschr Med; 2014 Feb; 156(2):50-2. PubMed ID: 24934056
    [No Abstract]   [Full Text] [Related]  

  • 31. [Rivaroxaban, dabigatran and apixaban: new anticoagulants in operative urology].
    John A; Michel MS
    Urologe A; 2014 Jun; 53(6):893-902; quiz 903. PubMed ID: 24845012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New oral anticoagulant agents - general features and outcomes in subsets of patients.
    Schulman S
    Thromb Haemost; 2014 Apr; 111(4):575-82. PubMed ID: 24452881
    [TBL] [Abstract][Full Text] [Related]  

  • 33. I recently heard that there are alternative medications to the blood thinner warfarin. What are they, and how are they different?
    Duke Med Health News; 2012 Jan; 18(1):8. PubMed ID: 22324070
    [No Abstract]   [Full Text] [Related]  

  • 34. Mixed treatment comparison meta-analysis of aspirin, warfarin, and new anticoagulants for stroke prevention in patients with nonvalvular atrial fibrillation.
    Assiri A; Al-Majzoub O; Kanaan AO; Donovan JL; Silva M
    Clin Ther; 2013 Jul; 35(7):967-984.e2. PubMed ID: 23870607
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical management of the new anticoagulants].
    Zapata Wainberg G; Ximénez-Carrillo Rico A; Vivancos Mora J
    Neurologia; 2012 Mar; 27 Suppl 1():33-8. PubMed ID: 22682208
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical review: Clinical management of new oral anticoagulants: a structured review with emphasis on the reversal of bleeding complications.
    Lazo-Langner A; Lang ES; Douketis J
    Crit Care; 2013 Jun; 17(3):230. PubMed ID: 23806169
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Periprocedural antithrombotic and bridging therapy: recommendations for standardized reporting in patients with arterial indications for chronic oral anticoagulant therapy.
    Spyropoulos AC; Douketis JD; Gerotziafas G; Kaatz S; Ortel TL; Schulman S;
    J Thromb Haemost; 2012 Apr; 10(4):692-4. PubMed ID: 22934291
    [No Abstract]   [Full Text] [Related]  

  • 38. New approaches to reversing oral anticoagulant therapy. Introduction.
    Nutescu EA
    Am J Health Syst Pharm; 2013 May; 70(10 Suppl 1):S1-2. PubMed ID: 23640527
    [No Abstract]   [Full Text] [Related]  

  • 39. Recent advances in antithrombotic therapy for stroke prevention in patients with atrial fibrillation.
    Lenchus JD
    Hosp Pract (1995); 2013 Feb; 41(1):49-60. PubMed ID: 23466967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Anticoagulation in atrial fibrillation: a new era has begun].
    Moser M; Bode C
    Hamostaseologie; 2012; 32(1):37-9. PubMed ID: 22124808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.